• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Assessment and management of peripheral arterial disease: what every cardiologist should know.

作者信息

Tran Bao

机构信息

Cardiology, St Mary's Medical Center, San Francisco, California, USA

出版信息

Heart. 2021 Nov;107(22):1835-1843. doi: 10.1136/heartjnl-2019-316164. Epub 2021 May 13.

DOI:10.1136/heartjnl-2019-316164
PMID:33985986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8562307/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/b2c2a7fdbaca/heartjnl-2019-316164f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/dd1405aeeed0/heartjnl-2019-316164f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/d977e00a750b/heartjnl-2019-316164f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/ae515fd23138/heartjnl-2019-316164f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/b2c2a7fdbaca/heartjnl-2019-316164f04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/dd1405aeeed0/heartjnl-2019-316164f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/d977e00a750b/heartjnl-2019-316164f02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/ae515fd23138/heartjnl-2019-316164f03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9462/8562307/b2c2a7fdbaca/heartjnl-2019-316164f04.jpg

相似文献

1
Assessment and management of peripheral arterial disease: what every cardiologist should know.外周动脉疾病的评估与管理：每位心脏病专家都应了解的知识。
Heart. 2021 Nov;107(22):1835-1843. doi: 10.1136/heartjnl-2019-316164. Epub 2021 May 13.
2
[SICI-GISE position paper on the requirements for diagnostic and interventional procedures in patients with peripheral arterial disease].[SICI-GISE关于外周动脉疾病患者诊断和介入程序要求的立场文件]
G Ital Cardiol (Rome). 2013 Oct;14(10):690-8. doi: 10.1714/1335.14837.
3
Sexual function and cardiovascular disease: what the general cardiologist needs to know.性功能与心血管疾病：普通心脏病专家需要了解的内容。
Heart. 2019 Jan;105(2):160-168. doi: 10.1136/heartjnl-2016-310762. Epub 2018 Sep 5.
4
Liver and Cardiovascular Disease: What Cardiologists Need to Know About Ultrasound Findings.肝脏与心血管疾病：心脏病专家需要了解的超声检查结果
Rev Esp Cardiol (Engl Ed). 2017 May;70(5):399-401. doi: 10.1016/j.rec.2016.09.013. Epub 2016 Oct 18.
5
SCAI 2018 Think Tank Proceedings: "What skillsets are required of vascular interventional cardiologists in evaluating and managing critical limb ischemia (CLI)? What role should SCAI play in supporting interventional cardiologists in their CLI practices, individually and collectively?".SCAI 2018 智库会议记录：“血管介入心脏病学家在评估和管理严重肢体缺血 (CLI) 时需要具备哪些技能？SCAI 应该在哪些方面发挥作用，以支持介入心脏病学家在其 CLI 实践中，单独和集体地发挥作用？”
Catheter Cardiovasc Interv. 2019 Feb 15;93(3):511-513. doi: 10.1002/ccd.27900. Epub 2018 Nov 29.
6
The Translation of Knowledge Into Practice in the Management of Atrial Fibrillation in Singapore.新加坡心房颤动管理中知识向实践的转化
Heart Lung Circ. 2019 Apr;28(4):605-614. doi: 10.1016/j.hlc.2018.02.024. Epub 2018 Mar 12.
7
[ESC guidelines 2017 on peripheral arterial diseases : Summary of the most important recommendations and innovations].[2017年欧洲心脏病学会外周动脉疾病指南：最重要建议及创新要点总结]
Herz. 2017 Dec;42(8):721-727. doi: 10.1007/s00059-017-4638-2.
8
PCR Peripheral @ GISE: a unique educational link between peripheral endovascular solutions and interventional cardiologists.PCR外周血管介入课程@全球介入心血管病学峰会：外周血管腔内治疗解决方案与介入心脏病专家之间独特的教育纽带。
EuroIntervention. 2017 Oct 13;13(9):e1013-e1017. doi: 10.4244/EIJV13I9A154.
9
Tort Reform and the Cardiologist.侵权法改革与心脏病专家
J Am Coll Cardiol. 2017 Jul 11;70(2):290-292. doi: 10.1016/j.jacc.2017.05.054.
10
[Management of peripheral vascular disease based on current guidelines. Peripheral artery occlusive disease of the iliac and femoral arteries and carotid artery stenosis].[基于现行指南的周围血管疾病管理。髂股动脉周围动脉闭塞性疾病和颈动脉狭窄]
Herz. 2013 Dec;38(8):848-54. doi: 10.1007/s00059-013-3985-x.

引用本文的文献

1
Clinical management of peripheral arterial disease in chronic kidney disease-a comprehensive review from the European Renal Association CKD-MBD Working Group.慢性肾脏病患者外周动脉疾病的临床管理——欧洲肾脏协会慢性肾脏病-矿物质与骨异常工作组的全面综述
Clin Kidney J. 2025 Apr 7;18(5):sfaf089. doi: 10.1093/ckj/sfaf089. eCollection 2025 May.
2
Accuracy of segment anything model for classification of vascular stenosis in digital subtraction angiography.用于数字减影血管造影中血管狭窄分类的任何分割模型的准确性
CVIR Endovasc. 2025 May 19;8(1):45. doi: 10.1186/s42155-025-00560-z.
3
Exploring the hemoglobin-to-red blood cell distribution width ratio (HRR) to peripheral arterial disease nexus: a comprehensive analysis of NHANES data from 1999 to 2004.

本文引用的文献

1
Mortality with Paclitaxel-Coated Devices in Peripheral Artery Disease.紫杉醇涂层器械在外周动脉疾病中的死亡率。
N Engl J Med. 2020 Dec 24;383(26):2538-2546. doi: 10.1056/NEJMoa2005206. Epub 2020 Dec 9.
2
Rivaroxaban in Peripheral Artery Disease after Revascularization.利伐沙班治疗血管重建术后外周动脉疾病
N Engl J Med. 2020 May 21;382(21):1994-2004. doi: 10.1056/NEJMoa2000052. Epub 2020 Mar 28.
3
Stenting for symptomatic vertebral artery stenosis: a preplanned pooled individual patient data analysis.支架置入治疗有症状性椎动脉狭窄：一项预先计划的个体化患者数据汇总分析。
探索血红蛋白与红细胞分布宽度比值（HRR）与外周动脉疾病的关系：对1999年至2004年美国国家健康与营养检查调查（NHANES）数据的综合分析。
Front Pharmacol. 2025 Jan 22;16:1529155. doi: 10.3389/fphar.2025.1529155. eCollection 2025.
4
Genetic association between immune-mediated inflammatory diseases and peripheral artery disease: a Mendelian randomization study.免疫介导的炎症性疾病与外周动脉疾病之间的遗传关联：一项孟德尔随机化研究。
Sci Rep. 2025 Jan 31;15(1):3891. doi: 10.1038/s41598-024-82987-3.
5
Associations of Metabolic Dysfunction-Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study.代谢功能障碍相关脂肪性肝病与外周动脉疾病的相关性：英国生物库和 ARIC 研究的前瞻性分析。
J Am Heart Assoc. 2024 Nov 19;13(22):e035265. doi: 10.1161/JAHA.124.035265. Epub 2024 Nov 15.
6
Comparison of efficacy and safety of sarpogrelate-based anti-platelet therapy with non-sarpogrelate-based anti-platelet therapy following arterial endovascular therapy: a systematic review.动脉血管内治疗后基于沙格雷酯的抗血小板治疗与非基于沙格雷酯的抗血小板治疗的疗效和安全性比较：一项系统评价
Ann Med Surg (Lond). 2024 Aug 22;86(10):6071-6078. doi: 10.1097/MS9.0000000000002373. eCollection 2024 Oct.
7
A Comprehensive Review of Cardiovascular Disease Management: Cardiac Biomarkers, Imaging Modalities, Pharmacotherapy, Surgical Interventions, and Herbal Remedies.心血管疾病管理的综合述评：心脏生物标志物、成像方式、药物治疗、手术干预和草药疗法。
Cells. 2024 Sep 1;13(17):1471. doi: 10.3390/cells13171471.
8
Importance of Using Angiography for the Early Detection of Chronic Limb Ischemia in Diabetic Foot Wounds.血管造影术在糖尿病足伤口慢性肢体缺血早期检测中的应用重要性
Cureus. 2024 Jun 7;16(6):e61906. doi: 10.7759/cureus.61906. eCollection 2024 Jun.
9
Complex Peripheral Arterial Disease in a Case of Multilevel Lesions Treated With Sequential Angioplasty.序贯血管成形术治疗多节段病变患者的复杂外周动脉疾病
Cureus. 2024 May 24;16(5):e60982. doi: 10.7759/cureus.60982. eCollection 2024 May.
10
Clinical physiology: the crucial role of MRI in evaluation of peripheral artery disease.临床生理学：MRI 在周围动脉疾病评估中的关键作用。
Am J Physiol Heart Circ Physiol. 2024 May 1;326(5):H1304-H1323. doi: 10.1152/ajpheart.00533.2023. Epub 2024 Mar 22.
Lancet Neurol. 2019 Jul;18(7):666-673. doi: 10.1016/S1474-4422(19)30149-8. Epub 2019 May 23.
4
Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial.依洛尤单抗治疗多血管疾病及近期急性冠状动脉综合征患者：ODYSSEY OUTCOMES 试验。
J Am Coll Cardiol. 2019 Sep 3;74(9):1167-1176. doi: 10.1016/j.jacc.2019.03.013. Epub 2019 Mar 18.
5
When and How Should We Revascularize Patients With Atherosclerotic Renal Artery Stenosis?何时及如何对粥样动脉硬化性肾动脉狭窄患者进行血运重建？
JACC Cardiovasc Interv. 2019 Mar 25;12(6):505-517. doi: 10.1016/j.jcin.2018.10.023.
6
Risk of Death Following Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery of the Leg: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.紫杉醇涂层球囊和支架在下肢股腘动脉中的应用死亡风险：随机对照试验的系统评价和荟萃分析。
J Am Heart Assoc. 2018 Dec 18;7(24):e011245. doi: 10.1161/JAHA.118.011245.
7
ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison.ACC/AHA 与 ESC 外周动脉疾病诊断与管理指南：JACC 指南比较
J Am Coll Cardiol. 2018 Dec 4;72(22):2789-2801. doi: 10.1016/j.jacc.2018.09.041.
8
Determinants of Long-Term Outcomes and Costs in the Management of Critical Limb Ischemia: A Population-Based Cohort Study.关键肢体缺血管理的长期结局和成本的决定因素：一项基于人群的队列研究。
J Am Heart Assoc. 2018 Aug 21;7(16):e009724. doi: 10.1161/JAHA.118.009724.
9
Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).外周动脉疾病患者诊断与管理问答：2017年欧洲心脏病学会外周动脉疾病诊断与治疗指南的配套文件，与欧洲血管外科学会（ESVS）合作编写
Eur J Vasc Endovasc Surg. 2018 Apr;55(4):457-464. doi: 10.1016/j.ejvs.2017.08.014. Epub 2018 Apr 6.
10
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA Study.严重冠状动脉疾病患者中联合强化二级预防的多血管病变的系统检测：随机 AMERICA 研究。
Int J Cardiol. 2018 Mar 1;254:36-42. doi: 10.1016/j.ijcard.2017.11.081. Epub 2018 Jan 28.